Bordetella

Bordetella are gram-negative cocobacilli, in human they colonize mainly the ciliated epithelium of the upper respiratory tract. Human pathogens include B. pertussis a B. parapertussis, pertussis or parapertussis agent. The other B. bronchoseptica, B. avium, B. hinzii, B. holmesii a B. trematum.



Bordetella pertussis
Bordetella pertussis is a short, immobile rod with ovoid shape. It has a unique ability to colonize epithelial cilia in the airways. B. pertussis is a human pathogen. It is the cause of whooping cough, which was considered one of the most serious diseases of infants and children until vaccination was introduced.

Morphology

 * ovoid stationary rod
 * gram-negative

Physiology

 * strictly aerobic, immobile, non-sporulating
 * requires enriched soils

Cultivation

 * suitable culture medium is Bordet-Gengou medium, agar with defibrinated sheep blood, potato infusion and glycerol
 * colonies grow after 36-72 hours, are small, translucent with a pearlescent luster and a narrow hemolysis zone around them

Laboratory diagnosis

 * nasopharyngeal swab, first the swabs are rinsed with a drop of penicillin to prevent the growth of gram-positive microorganisms, and then spirally inoculated on Bordet-Gengou soil
 * identification by agglutination with a specific antiserum, agglutination, precipitation antibodies can be detected within three weeks

Antigens and toxicity
B. pertussis produces immunologicaly and pathophysiologicaly unique responses in the macroorganism. Most of these effects are caused by pertussis toxin (PT).


 * Pertussis toxin is composed of two types of subunits A (active enzyme) and B (binding subunit). The A-subunit is an ADP-ribosyl transferase that transfers the ADP-ribosyl portion of NAD to the membrane-bound regulatory protein. This protein physiologically inhibits adenyl cyclase, resulting in stimulation by toxin inactivation.
 * Pertussis toxin causes hypoglycemia by stimulating insulin production. PT also increases histamine sensitivity and enhances capillary permeability.
 * B. pertussis produces a lethal toxin (dermonecrotic toxin) causing local necrosis after intradermal injection.
 * Another product is tracheal cytotoxin, which is toxic to the ciliated airway epithelium.

Pathogenesis
B. pertussis adheres to the mucosal surface of the trachea and bronchi, where it rapidly multiplies and blocks cilia function. Residues of microorganisms contain a toxin that is released and irritates the mucous membranes, induces lymphocytosis and causes bluetongue to necrosis of the mucosal epithelium. However, the brothels do not get into the bloodstream. Peribronchitis and, due to the blockage of mucociliary transport, an irritating cough develops.

Disease

 * Pertussis (whooping cough)

Treatment
Hyperimmune immunoglobulin can be used for children under the age of two at an early stage of the disease. Antibiotic therapy reduces acute toxicity and prevents pulmonary complications, chloramphenicol is given. Erythromycin or ampicillin are suitable.

Prevention
Vaccination in the Czech Republic since 1958. Since 2007 as a part of hexavaccine.